OTW Delivery System
*The above diagram is just an illustration of the product.
Disclaimer: The law restricts these devices to sale by or on the order of a physician. Indications, contradictions, warnings can be found in the product
labelling / IFU supplied with each device. For restricted use only in countries where product is registered with applicable health authorities.
MAGICTOUCH PTA
Magic Touch PTA is intended for percutaneous transluminal angioplasty of de-novo, stenotic and instent restenotic lesions in Superficial femoral (SFA), popliteal, Below The Knee (BTK) and iliac arteries.
Magic Touch PTA designed by propriety NANOLUTE Technology, works as an excellent alternative for revascularization of SFA, popliteal, BTK and iliac arteries by preventing re-narrowing of that arteries.
UNIQUE COATING TECHNOLOGY
Magic Touch PTA developed with Nanolute Technology possesses unique circumferential coating technology that facilitates homogeneous drug distribution to target lesions.
COATING
Low pressure inflation and
then coating is performed
REFOLDING
INFLATION
Circumferential coating
(100% surface area coated)
NANOLUTE TECHNOLOGY
ADVANTAGES OF NANOLUTE TECHNOLOGY
SIROLIMUS DISTRIBUTION STUDY
DTF labelled Sirolimus was used to assess the drug distribution following DCB treatment*
A: Adventitia; EEL: External Elastic Lamina; IEL: Internal Elastic Lamina; L: Lumen; M: Media *EuroIntervention. 2013 May 20;9(1): 148-56